Michael D. Loberg, Director at IGM Biosciences, Inc. (IGMS), bought 22,572 shares at $23.00 ($500K) on 2022-04-01, disclosed to the SEC on 2022-04-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 300 | $0 | 0.0% |
| 2 | $0.00 | 533 | $0 | 0.0% |
| 3 | $23.00 | 21,739 | $500K | 100.0% |
| Total | $22.15 avg | 22,572 | $500K | 100% |
| Filing → |
| IGMS | BUY | 2019-09-20 | $93K | — | Filing → |
| ARQL | BUY | 2015-12-18 | $8K | — | Filing → |
| ARQL | BUY | 2015-12-17 | $3K | — | Filing → |